<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article article-type="abstract" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CC</journal-id>
<journal-id journal-id-type="nlm-ta">Cardiol Croat</journal-id>
<journal-title-group>
<journal-title>Cardiologia Croatica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Cardiol. Croat.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1848-543X</issn>
<issn pub-type="epub">1848-5448</issn>
<publisher><publisher-name>Croatian Cardiac Society</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">CC 2024 19_11-12_550</article-id>
<article-id pub-id-type="doi">10.15836/ccar2024.550</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Extended Abstract</subject></subj-group>
<subj-group subj-group-type="subheading"><subject>Acute and intensive cardiology</subject></subj-group>
</article-categories>
<title-group>
<article-title>Pulmonary embolism in neuroleptic malignant syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5767-1206</contrib-id><name><surname>Petreti&#x0107;</surname><given-names>Ana</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1">*</xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4257-0178</contrib-id><name><surname>Tomac Stojmenovi&#x0107;</surname><given-names>Marija</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<aff id="aff1"><label>1</label><institution>University Hospital Rijeka</institution>, <addr-line>Rijeka</addr-line>, <country country="hr">Croatia</country></aff>
<aff id="aff2"><label>2</label><institution>University of Rijeka</institution>, <institution content-type="dept">Faculty of Medicine</institution>, <addr-line>Rijeka</addr-line>, <country country="hr">Croatia</country></aff>
<aff id="aff3"><label>3</label><institution>Insula County Hospital, Rab</institution>, <country country="hr">Croatia</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>ADDRESS FOR CORRESPONDENCE: Ana Petreti&#x0107;, Klini&#x010D;ki bolni&#x010D;ki centar Rijeka, Tome Stri&#x017E;i&#x0107;a 3, HR-51000 Rijeka, Croatia. / Phone: +385-91-5350-834 / E-mail: <email xlink:href="aantonic326@gmail.com">aantonic326@gmail.com</email></corresp></author-notes>
<pub-date date-type="pub" publication-format="electronic"><month>11</month><year>2024</year></pub-date>
<pub-date date-type="pub" publication-format="print"><month>11</month><year>2024</year></pub-date>
<volume>19</volume>
<issue>11-12</issue>
<fpage>550</fpage>
<lpage>550</lpage>
<history>
<date date-type="received"><day>20</day><month>09</month><year>2024</year></date>
<date><day>31</day><month>10</month><year>2024</year></date>
</history>
<permissions>
<copyright-statement>Croatian Cardiac Society</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Croatian Cardiac Society</copyright-holder>
</permissions>
<kwd-group kwd-group-type="author"><title>KEYWORDS: </title><kwd>neuroleptic malignant syndrome</kwd><kwd>pulmonary embolism</kwd><kwd>antipsychotics</kwd></kwd-group>
</article-meta>
</front>
<body>
<p><bold>Introduction</bold>: Malignant neuroleptic syndrome (MNS) is life-threatening condition caused by psychotropic medications (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>, <xref ref-type="bibr" rid="r2"><italic>2</italic></xref>). Pulmonary embolism is known complication of antipsychotics, but incidence of pulmonary embolism in MNS is not known. Raised levels of creatine kinase can be helpful in diagnose but are not specific for MNS and there are cases with normal levels. (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>)</p>
<p><bold>Case report</bold>: We present the case of a 59-year-old female with severe bipolar disorder who presented with high fever, altered mental status and acute respiratory insufficiency. Upon presentation she was hospitalized in local institution for worsening of mental status receiving typical and atypical neuroleptics. On fourteenth day of hospitalization on psychiatric ward she was transferred to our Clinic because of acute respiratory insufficiency. High fever and altered mental status preceded, together with tachycardia and tachypnea but without hemodynamic instability. In laboratory tests special attention was on creatine kinase level which was not elevated. Before transport analgosedation and orotracheal intubation was preformed and she was mechanically ventilated. Upon admission CT pulmonary angiography showed bilateral pulmonary thromboembolism. Patient developed hemodynamic instability requiring vasopressors so systemic fibrinolytic therapy was applied. Hospitalization was complicated with severe thrombocytopenia, acute kidney failure, prolonged and difficult weaning from ventilator (with need of tracheostomy), partial epileptic seizures, bacteriemia (Staphylococcus species), and tetraparesis following prolonged immobility. Slowly, on tailored medical therapy together with intensive physiotherapy patient started to recover physically but then her mental status started to deteriorate again.</p>
<p><bold>Conclusion</bold>: According to patient history, drug therapy, clinical presentation and excluded other possible causes we conclude that patient had MNS. Prompt reaction and therapy is necessary to reduce mortality in such lethal condition.</p>
</body>
<back>
<ref-list>
<title>LITERATURE</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berman</surname><given-names>BD</given-names></name></person-group>. <article-title>Neuroleptic malignant syndrome: a review for neurohospitalists.</article-title> <source>Neurohospitalist</source>. <year>2011</year> January;<volume>1</volume>(<issue>1</issue>):<fpage>41</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1177/1941875210386491</pub-id><pub-id pub-id-type="pmid">23983836</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duma</surname><given-names>SR</given-names></name><name><surname>Fung</surname><given-names>VS</given-names></name></person-group>. <article-title>Drug-induced movement disorders.</article-title> <source>Aust Prescr</source>. <year>2019</year> April;<volume>42</volume>(<issue>2</issue>):<fpage>56</fpage>&#x2013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.18773/austprescr.2019.014</pub-id><pub-id pub-id-type="pmid">31048939</pub-id></mixed-citation></ref>
<ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maniam</surname><given-names>T</given-names></name><name><surname>Rahman</surname><given-names>MA</given-names></name></person-group>. <article-title>All elevated creatine kinase is not neuroleptic malignant syndrome.</article-title> <source>Med J Malaysia</source>. <year>1994</year> September;<volume>49</volume>(<issue>3</issue>):<fpage>252</fpage>&#x2013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">7845275</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
